SubjectWell

SubjectWell, founded in 2012 and headquartered in the United States, is revolutionizing patient recruitment for clinical trials as a global patient recruitment platform. As the premier Patient Experience Platform, the company streamlines patient recruitment processes, enhances patient engagement, and optimizes retention by refining the patient journey from protocol design through study completion.

By leveraging its creative strategy, global reach, scientific insight, specialized services, and advanced technology, SubjectWell aims to deliver intelligence, predictability, and operational efficiency for sponsors, CROs, research sites, and site networks. The company recently secured a $35.00M Series B investment on 20 October 2022 from prominent investors, including Asset Management Ventures, Healthy Ventures, Frontier Venture Capital, Windham Venture Partners, Geekdom Fund, Bertelsmann Investments, and Salmira Investment Fund. Their support reflects strong confidence in SubjectWell's potential to innovate the clinical trial landscape.